HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

N Uhrhammer Selected Research

taxane

8/2014Multicentric neoadjuvant phase II study of panitumumab combined with an anthracycline/taxane-based chemotherapy in operable triple-negative breast cancer: identification of biologically defined signatures predicting treatment impact.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


N Uhrhammer Research Topics

Disease

4Neoplasms (Cancer)
08/2014 - 09/2000
1Triple Negative Breast Neoplasms
08/2014
1Breast Neoplasms (Breast Cancer)
07/2007
1Hallux Valgus
02/2007
1Atherosclerosis
02/2007
1Alopecia (Baldness)
02/2007
1Cataract (Cataracts)
02/2007
1Myeloid Sarcoma (Chloroma)
02/2007
1Flatfoot (Flat Feet)
02/2007
1BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
01/2006
1Colorectal Neoplasms (Colorectal Cancer)
03/2000

Drug/Important Bio-Agent (IBA)

1Panitumumab (Vectibix)FDA Link
08/2014
1taxaneIBA
08/2014
1ParaffinIBA
08/2014
1Biomarkers (Surrogate Marker)IBA
08/2014
1Growth Factor ReceptorsIBA
08/2014
1AnthracyclinesIBA
08/2014
1Keratin-8 (Keratin 8)IBA
08/2014
1Monoclonal AntibodiesIBA
07/2007
1BRCA1 ProteinIBA
07/2007
1Nuclear Proteins (Protein, Nuclear)IBA
07/2007
1Imatinib Mesylate (Gleevec)FDA Link
01/2006
1Proteins (Proteins, Gene)FDA Link
09/2000
1DNA (Deoxyribonucleic Acid)IBA
03/2000

Therapy/Procedure

1Drug Therapy (Chemotherapy)
08/2014
1Hair Removal (Depilation)
02/2007